← Evidence map

ArticleAutoimmunity reviews2020

Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection.

Louise Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32380318